Special issue: New Insights into Cyclodextrin-Based Drug Delivery Systems
In recent decades, the biomedical and pharmaceutical potential of cyclodextrins has expanded remarkably. Their well‑established host–guest complexation ability continues to
Category: Drug delivery
Oral Treatment of Obesity by GLP-1 and Its Analogs
Obesity is a multifaceted disease that significantly increases the risk of various chronic conditions. GLP-1R (co)-agonists first emerged as therapeutics
Special issue: Advanced Polymeric Biomaterials for Drug Delivery Applications
The present Special Issue in Polymers welcomes contributions in the form of original research articles, preclinical investigations, or review articles
Nitric Oxide-Releasing Thixotropic Hydrogels as Antibacterial and Hemocompatible Catheter Locks
Catheter locks are used to prevent infection and clotting in indwelling catheters, but most current locks are simple liquids. These
5th International Conference Integrative Chemistry, Biology & Translational Medicine
The conference will be held on 25-27 June 2026 in Debrecen. The journey of ICBTM began in 2019 with the
Cyclodextrin Polymer Complexation Improves the Tolerability of Parenteral Oestradiol
This study investigates the PEG‑β‑CD polymer, a water‑soluble polyethylene glycol–β‑cyclodextrin cross‑linked carrier, as a potential alternative to conventional oestradiol formulations
Enhancing the Water Solubility and Efficacy of Anticancer Drugs Using Hydroxypropyl-β-Cyclodextrin
Previous studies have demonstrated that the solubility and biocompatibility of poorly water-soluble anti-cancer agents can be improved by complexation with
Dimethylated β-cyclodextrin inclusion complexes containing the guest steroid hormones progesterone and 17β-estradiol: syntheses, crystal structures, thermal analyses and steroid solubility enhancements
The aim of the present study was to complex the potent steroidal hormones progesterone (PRO) and 17β-estradiol (BES) with heptakis(2,6-di-O-methyl)-β-cyclodextrin
New FDA approved medicinal product containing Betadex sulfobutylether sodium: VYKOURA
VYKOURA is a newly approved medication (marketing start date: 02/03/2026) containing leucovorin calcium, a prescription injectable drug used in hospital
Betadex sulfobutylether sodium — a key enabler for potent neurotherapeutics
In the search for better therapies for neurodegenerative diseases like Parkinson’s, researchers are increasingly looking beyond classical drugs to the